ID

39053

Beschreibung

Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01040871

Link

https://clinicaltrials.gov/show/NCT01040871

Stichworte

Versionen (1)
  1. 24.11.19 24.11.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

24. November 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diffuse Large B-Cell Lymphoma NCT01040871

Englisch

Eligibility Diffuse Large B-Cell Lymphoma NCT01040871

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female patients 18 years or older.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
newly diagnosed non-gcb subtype of dlbcl (stage ii, iii or iv).
Beschreibung

Diffuse Large B-Cell Lymphoma TNM clinical staging | Exception Germinal Center B-Cell Type

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079744
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1333295
at least 1 measurable site of disease.
Beschreibung

Measurable Disease Site Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1515974
UMLS CUI [1,3]
C1265611
eastern cooperative oncology group (ecog) performance status 0-2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
female subjects must be postmenopausal (for at least 6 months), surgically sterile, abstinent, or, if sexually active, be practicing an effective method of birth control before entry and throughout the study; and have a negative pregnancy test at screening.
Beschreibung

Postmenopausal state | Female Sterilization | Gender Sexual Abstinence | Gender Sexually active Contraceptive methods | Gender Pregnancy test negative

Datentyp

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2]
C0015787
UMLS CUI [3,1]
C0079399
UMLS CUI [3,2]
C0036899
UMLS CUI [4,1]
C0079399
UMLS CUI [4,2]
C0241028
UMLS CUI [4,3]
C0700589
UMLS CUI [5,1]
C0079399
UMLS CUI [5,2]
C0427780
male subjects must agree to use a double barrier method of birth control
Beschreibung

Gender Barrier Contraception Double

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0004764
UMLS CUI [1,3]
C0205173
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment with velcade.
Beschreibung

Velcade

Datentyp

boolean

Alias
UMLS CUI [1]
C1174739
prior extended radiotherapy or chemotherapy for lymphoma
Beschreibung

Therapeutic radiology procedure Extended Lymphoma | Chemotherapy Extended Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0231448
UMLS CUI [1,3]
C0024299
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0231448
UMLS CUI [2,3]
C0024299
more than 150 mg/m2 of prior doxorubicin
Beschreibung

Doxorubicin Dosage

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C0178602
major surgery within 3 weeks of study.
Beschreibung

Major surgery

Datentyp

boolean

Alias
UMLS CUI [1]
C0679637
peripheral neuropathy or neuralgia of grade 2 or worse.
Beschreibung

Peripheral Neuropathy CTCAE grades | Neuralgia CTCAE grades

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
UMLS CUI [2,1]
C0027796
UMLS CUI [2,2]
C1516728
active cns lymphoma
Beschreibung

Central nervous system lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0742472
diagnosed or treated for a malignancy other than nhl, with some exceptions
Beschreibung

Malignant Neoplasms | Cancer treatment | Exception Non-Hodgkin Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0920425
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0024305
pregnant or breast feeding
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
active systemic infection
Beschreibung

Sepsis

Datentyp

boolean

Alias
UMLS CUI [1]
C0243026
documented of suspected human immunodeficiency virus (hiv)/aids
Beschreibung

HIV Infection Suspected | AIDS Suspected

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019693
UMLS CUI [1,2]
C0750491
UMLS CUI [2,1]
C0001175
UMLS CUI [2,2]
C0750491
uncontrolled or severe cardiovascular disease
Beschreibung

Cardiovascular Disease Uncontrolled | Cardiovascular Disease Severe

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0007222
UMLS CUI [2,2]
C0205082
known allergies, hypersensitivity or intolerance to study drugs
Beschreibung

Hypersensitivity Investigational New Drugs | Intolerance to Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0013230
serious medical condition that could interfere with study
Beschreibung

Medical condition Interferes with Clinical Trial

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0008976
concurrent treatment with another investigational agent
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Diffuse Large B-Cell Lymphoma NCT01040871

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male or female patients 18 years or older.
boolean
C0001779 (UMLS CUI [1])
Diffuse Large B-Cell Lymphoma TNM clinical staging | Exception Germinal Center B-Cell Type
Item
newly diagnosed non-gcb subtype of dlbcl (stage ii, iii or iv).
boolean
C0079744 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C1333295 (UMLS CUI [2,2])
Measurable Disease Site Quantity
Item
at least 1 measurable site of disease.
boolean
C1513041 (UMLS CUI [1,1])
C1515974 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Postmenopausal state | Female Sterilization | Gender Sexual Abstinence | Gender Sexually active Contraceptive methods | Gender Pregnancy test negative
Item
female subjects must be postmenopausal (for at least 6 months), surgically sterile, abstinent, or, if sexually active, be practicing an effective method of birth control before entry and throughout the study; and have a negative pregnancy test at screening.
boolean
C0232970 (UMLS CUI [1])
C0015787 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0036899 (UMLS CUI [3,2])
C0079399 (UMLS CUI [4,1])
C0241028 (UMLS CUI [4,2])
C0700589 (UMLS CUI [4,3])
C0079399 (UMLS CUI [5,1])
C0427780 (UMLS CUI [5,2])
Gender Barrier Contraception Double
Item
male subjects must agree to use a double barrier method of birth control
boolean
C0079399 (UMLS CUI [1,1])
C0004764 (UMLS CUI [1,2])
C0205173 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Velcade
Item
prior treatment with velcade.
boolean
C1174739 (UMLS CUI [1])
Therapeutic radiology procedure Extended Lymphoma | Chemotherapy Extended Lymphoma
Item
prior extended radiotherapy or chemotherapy for lymphoma
boolean
C1522449 (UMLS CUI [1,1])
C0231448 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C0231448 (UMLS CUI [2,2])
C0024299 (UMLS CUI [2,3])
Doxorubicin Dosage
Item
more than 150 mg/m2 of prior doxorubicin
boolean
C0013089 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Major surgery
Item
major surgery within 3 weeks of study.
boolean
C0679637 (UMLS CUI [1])
Peripheral Neuropathy CTCAE grades | Neuralgia CTCAE grades
Item
peripheral neuropathy or neuralgia of grade 2 or worse.
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C0027796 (UMLS CUI [2,1])
C1516728 (UMLS CUI [2,2])
Central nervous system lymphoma
Item
active cns lymphoma
boolean
C0742472 (UMLS CUI [1])
Malignant Neoplasms | Cancer treatment | Exception Non-Hodgkin Lymphoma
Item
diagnosed or treated for a malignancy other than nhl, with some exceptions
boolean
C0006826 (UMLS CUI [1])
C0920425 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0024305 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Sepsis
Item
active systemic infection
boolean
C0243026 (UMLS CUI [1])
HIV Infection Suspected | AIDS Suspected
Item
documented of suspected human immunodeficiency virus (hiv)/aids
boolean
C0019693 (UMLS CUI [1,1])
C0750491 (UMLS CUI [1,2])
C0001175 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
Cardiovascular Disease Uncontrolled | Cardiovascular Disease Severe
Item
uncontrolled or severe cardiovascular disease
boolean
C0007222 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Hypersensitivity Investigational New Drugs | Intolerance to Investigational New Drugs
Item
known allergies, hypersensitivity or intolerance to study drugs
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
Medical condition Interferes with Clinical Trial
Item
serious medical condition that could interfere with study
boolean
C3843040 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Investigational New Drugs
Item
concurrent treatment with another investigational agent
boolean
C0013230 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video